| 标题： | 中国肝细胞癌合并胆管癌栓诊治指南（2024版） |
| title： | Guideline for diagnosis and treatment of hepatocellular carcinoma with bile duct tumor thrombus in China(2024) |
| 版本： | 更新版 |
| version： | Updated |
| 分类： | 标准指南 |
| classification： | Standard guideline |
| 领域： | 诊疗 |
| field： | Diagnosis and Treatment |
| 国家和地区： | 中国 |
| Country and region： | China |
| 指南使用者： | 各等级医院从事肝癌相关工作的临床医师、技术人员及相关教学、科研工作人员 |
| Guide users： | Clinicians, technicians and related teaching and research staff engaged in liver cancer related work in hospitals of all levels |
| 证据分级方法： | Ia 证据源于对多项随机对照研究的Meta分析结果 Ib 证据源于至少一项设计良好的随机对照研究结果 IIa 证据源于至少一项设计良好的前瞻性非随机对照研究结果 IIb 证据源自至少一项设计良好的其他类型干预性临床研究结果 III 证据源于设计良好的非干预性研究，如描述性研究，相关性研究等 IV 证据源于专家委员会报告或权威专家的临床经验报道 |
| Evidence grading method： | Ia Evidences are originated from the meta-analysis results of various RCTs Ib Evidences are originated from the results of at least one well-designed RCT IIa Evidences are originated from the results of at least one well-designed perspective non-RCT IIb Evidences are originated from the results of at least one well-designed interventional clinical research of other type III Evidences are originated from the well-designed non-interventional clinical researches, such as descriptive researches and relevant researches IV Evidences are originated from the reports made by committee of experts or the clinical reports of authoritative experts |
| 制定单位： | 中国医师协会肝癌专业委员会 |
| Formulating unit： | Chinese Association of Liver Cancer and Chinese Medical Doctor Association |
| 注册时间： | 2024-04-24 |
| Registration time： | |
| 注册编号： | PREPARE-2024CN583 |
| Registration number： | |
| 指南制订的目的： | 目前，国际上对肝癌合并胆管癌栓的诊断与治疗研究较少且未达成共识。为我国肝癌合并胆管癌栓患者的规范化诊疗提供最新的指导性建议，为了适应肝癌合并胆管癌栓临床诊疗的发展变化，中国医师协会肝癌专业委员会发布了《中国肝细胞癌合并胆管癌栓诊治指南（2024版）》 。 |
| Purpose of the guideline： | At present, the international research on the diagnosis and treatment of hepatocellular carcinoma(HCC) complicated with bile duct tumor thrombus(BDTT) is few and no consensus has been reached. To provide the latest guiding suggestions for the standardized diagnosis and treatment of HCC with BDTT in China. In order to adapt to the development and changes of clinical diagnosis and treatment of HCC with BDTT, the Chinese Association of Liver Cancer of Chinese Medical Doctor Association issued the Guideline for diagnosis and treatment of hepatocellular carcinoma with bile duct tumor thrombus in China(2024) |
